Drug Delivery to the Lungs (DDL) 2022

Stop by to learn about Solstice® Air, a breakthrough medical propellant currently in clinical development for pressurized metered dose inhalers (pMDIs) with the ability to help reduce greenhouse gas emissions.

Edinburgh, United Kingdom

Dec 07 - Dec 09, 2022

Book an appointment

Add to My Calendar

Solstice® Air (HFO-1234ze(E), cGMP) is a near-zero global warming potential (GWP) alternative to hydrofluorocarbons. Solstice Air is non-flammable (per ASTM E-681 and ISO 10156), non-ozone depleting, and VOC-exempt (U.S. EPA and CARB).

Let's Connect!

Sign up to receive exclusive communications about offerings, events, news, surveys, special offers and related topics via telephone, email and other forms of electronic communication.